We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-11.59%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.6B
AUM Growth
-$3.29B
Cap. Flow
-$1.2B
Cap. Flow %
-8.83%
Top 10 Hldgs %
51.07%
Holding
116
New
14
Increased
50
Reduced
18
Closed
20

Top Buys

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$538M
2
RHT
Red Hat Inc
RHT
+$426M
3
AABA
Altaba Inc
AABA
+$393M
4
CI icon
Cigna
CI
+$220M
5
EQIX icon
Equinix
EQIX
+$196M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$1.51B
2
ESRX
Express Scripts Holding Company
ESRX
+$1.13B
3
COL
Rockwell Collins
COL
+$584M
4
DELL icon
Dell
DELL
+$430M
5
EVHC
Envision Healthcare Holdings Inc
EVHC
+$257M

Sector Composition

Rank Sector Weight
1 Communication Services 23.71%
2 Healthcare 20.15%
3 Technology 18.04%
4 Industrials 7.34%
5 Consumer Discretionary 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLRY icon
26
Tilray
TLRY
$632M
$162M 1.19%
247,952
– –
VRSK icon
27
Verisk Analytics
VRSK
$25.1B
$157M 1.15%
1,441,194
+16,641
+1% +$1.95M
CTXS
28
DELISTED
Citrix Systems Inc
CTXS
$150M 1.1%
1,468,234
-344,615
-19% -$36.4M
AZN icon
29
AstraZeneca
AZN
$241B
$148M 1.08%
1,942,500
+232,500
+14% +$18.2M
BABA icon
30
Alibaba
BABA
$309B
$144M 1.06%
1,050,000
+677,000
+182% +$100M
LBTYA icon
31
Liberty Global Class A
LBTYA
$3.72B
$127M 0.93%
5,972,437
-657,165
-10% -$16.1M
TSRO
32
DELISTED
TESARO, Inc.
TSRO
$126M 0.93%
+1,700,000
New +$81.7M
ARRS
33
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$109M 0.8%
+3,580,000
New +$99.5M
LBTYK icon
34
Liberty Global Class C
LBTYK
$3.6B
$102M 0.75%
4,937,202
-2,054,438
-29% -$49.2M
ASND icon
35
Ascendis Pharma A/S
ASND
$16B
$93.9M 0.69%
1,499,297
+42,000
+3% +$2.64M
XLRN
36
DELISTED
Acceleron Pharma
XLRN
$91.5M 0.67%
2,100,000
+259,268
+14% +$13M
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
$81.9M 0.6%
5,750,000
+625,000
+12% +$9.48M
MYOK
38
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$78.2M 0.57%
1,600,278
+69,000
+5% +$3.8M
ZGNX
39
DELISTED
Zogenix, Inc.
ZGNX
$74.8M 0.55%
2,050,500
+255,000
+14% +$10.4M
P
40
DELISTED
Pandora Media Inc
P
$74.5M 0.55%
+9,205,000
New +$79.5M
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.73B
$69.8M 0.51%
640,000
+445,000
+228% +$55.7M
ENTA icon
42
Enanta Pharmaceuticals
ENTA
$387M
$65.5M 0.48%
925,000
+57,500
+7% +$4.41M
CVS icon
43
CVS Health
CVS
$133B
$60.9M 0.45%
+930,000
New +$69.4M
GBT
44
DELISTED
Global Blood Therapeutics, Inc.
GBT
$59.5M 0.44%
1,450,000
+80,000
+6% +$3M
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$55.1M 0.4%
1,300,000
+425,000
+49% +$16.9M
IOVA icon
46
Iovance Biotherapeutics
IOVA
$1.95B
$50.7M 0.37%
5,725,000
+1,000,000
+21% +$9.64M
AMRN
47
Amarin Corp
AMRN
$302M
$47.6M 0.35%
175,000
+9,365
+6% +$3.41M
GRFS
48
Grifois
GRFS
$5.49B
$43.7M 0.32%
2,381,119
+591,119
+33% +$11.8M
NVCR icon
49
NovoCure
NVCR
$1.89B
$41.9M 0.31%
1,250,000
-100,000
-7% -$3.66M
ALNY icon
50
Alnylam Pharmaceuticals
ALNY
$29.3B
$40.1M 0.29%
550,000
+273,449
+99% +$21M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Farallon Capital Management held 116 positions worth $13.6B, down 19% from $16.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Farallon Capital Management withdrew a net $1.2B in Q4 2018, closing 20 positions and reducing 18 holdings. Its most notable exit was Aetna Inc, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Farallon Capital Management opened a new position in Red Hat Inc worth $472M.

  • Farallon Capital Management's largest Q4 2018 buy was Red Hat Inc: 2,685,000 shares worth $472M.
  • Farallon Capital Management added most to Twenty-First Century Fox, Inc. Class A in Q4 2018, an estimated $538M increase.
  • Farallon Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $430M.
  • Farallon Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $1.51B.
  • Farallon Capital Management's ten largest holdings make up 51% of its $13.6B portfolio in Q4 2018.
  • Farallon Capital Management opened 14 new positions and closed 20 in Q4 2018.
  • Farallon Capital Management's portfolio value fell 19% quarter-over-quarter to $13.6B.

Based on Farallon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.